ArticleBMC complementary medicine and therapies2025

Efficacy and safety of Chinese herbal medicine granules plus chemotherapy in patients with EGFR-mutated advanced lung adenocarcinoma post-progression on first-line EGFR-TKI: study protocol for a multicenter, double-blind, randomized controlled trial.

Yizhao Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.